Ramirez Asset Management’s AstraZeneca AZN Stock Holding History

Ramirez Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.72M	Buy	30,192 +2,683	+10%	+$505K	0.6%	56
2026 Q1	$5.42M	Buy	27,509 +2,878	+12%	+$555K	0.65%	53
2025 Q4	$4.53M	Buy	24,631 +1,302	+6%	+$228K	0.6%	58
2025 Q3	$3.58M	Sell	23,329 -1,265	-5%	-$191K	0.5%	74
2025 Q2	$3.44M	Buy	24,594 +5,102	+26%	+$715K	0.52%	62
2025 Q1	$2.87M	Sell	19,492 -6,955	-26%	-$1.01M	0.6%	52
2024 Q4	$3.47M	Buy	26,447 +404	+2%	+$56.6K	0.7%	50
2024 Q3	$4.06M	Buy	26,043 +566	+2%	+$91.4K	0.78%	40
2024 Q2	$3.97M	Sell	25,477 -1,017	-4%	-$153K	0.81%	37
2024 Q1	$3.59M	Sell	26,494 -1,208	-4%	-$160K	0.72%	44
2023 Q4	$3.73M	Sell	27,702 -513	-2%	-$66.7K	0.76%	42
2023 Q3	$3.82M	Buy	+28,215	New	+$3.85M	0.82%	33

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ramirez Asset Management's AZN Position: Q2 2026 in Review

Ramirez Asset Management increased its AstraZeneca (AZN) stake by 9.8% in Q2 2026, buying an estimated $505K and bringing the position to 30,192 shares worth $5.72M. The position accounts for 0.6% of the portfolio, ranked #56.

Ramirez Asset Management first reported a position in AZN in Q3 2023 and has held it in 12 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Ramirez Asset Management held 30,192 shares of AstraZeneca worth $5.72M as of Q2 2026.
Ramirez Asset Management bought 2,683 AstraZeneca shares in Q2 2026, an estimated $505K.
AstraZeneca made up 0.6% of Ramirez Asset Management's portfolio in Q2 2026, its #56 holding.
Ramirez Asset Management first reported a position in AstraZeneca in Q3 2023 and has held it in 12 quarters since.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Ramirez Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.